The levels and conformers of alpha-synuclein are critical in the pathogenesis of Parkinson's Disease and related synucleinopathies. Homeostatic mechanisms in protein degradation and secretion have been identified as regulators of alpha-synuclein at different stages of its intracellular trafficking and transcellular propagation. Here we review pathways involved in the removal of various forms of alpha-synuclein from both the intracellular and extracellular environment. Proteasomes and lysosomes are likely to play complementary roles in the removal of intracellular alpha-synuclein species, in a manner that depends on alpha-synuclein post-translational modifications. Extracellular alpha-synuclein is cleared by extracellular proteolytic enzymes...
Cytoplasmic alpha-synuclein (α-syn) aggregates, including Lewy bodies (LBs), are pathological hallma...
Accumulation of pathological alpha-synuclein aggregates plays a major role in Parkinson's diseas...
This concept article aims to show the rationale of targeting extracellular α-Synuclein (α-Syn) from ...
The levels and conformers of alpha‐synuclein are critical in the pathogenesis of Parkinson's Disease...
Parkinson's Disease (PD) is a complex neurodegenerative disorder classically characterized by moveme...
Alpha synuclein aggregation plays a central role in Parkinson's disease pathology. Direct transmissi...
Alpha-synuclein aggregation plays a central role in Parkinson's disease pathology. Direct transmissi...
Parkinson’s Disease (PD) is a complex neurodegenerative disorder classically characterized by moveme...
A major pathological feature of Parkinson’s disease (PD) is the aberrant accumulation of misfolded a...
Accepted Articles will appear in the futureInternational audienceA major pathological feature of Par...
AbstractAlpha-synuclein aggregation plays a central role in Parkinson's disease pathology. Direct tr...
alpha-Synuclein has been implicated in the pathogenesis of Parkinson's disease based on mutations in...
International audienceThe pathophysiology of Parkinson's disease, dementia with Lewy bodies, multipl...
ALpha-synuclein (alpha-syn) has been known to be a key player of the pathogenesis of Parkinson's dis...
Abstract Alpha-synuclein (aSyn) plays a crucial role in Parkinson’s disease (PD) and other synuclein...
Cytoplasmic alpha-synuclein (α-syn) aggregates, including Lewy bodies (LBs), are pathological hallma...
Accumulation of pathological alpha-synuclein aggregates plays a major role in Parkinson's diseas...
This concept article aims to show the rationale of targeting extracellular α-Synuclein (α-Syn) from ...
The levels and conformers of alpha‐synuclein are critical in the pathogenesis of Parkinson's Disease...
Parkinson's Disease (PD) is a complex neurodegenerative disorder classically characterized by moveme...
Alpha synuclein aggregation plays a central role in Parkinson's disease pathology. Direct transmissi...
Alpha-synuclein aggregation plays a central role in Parkinson's disease pathology. Direct transmissi...
Parkinson’s Disease (PD) is a complex neurodegenerative disorder classically characterized by moveme...
A major pathological feature of Parkinson’s disease (PD) is the aberrant accumulation of misfolded a...
Accepted Articles will appear in the futureInternational audienceA major pathological feature of Par...
AbstractAlpha-synuclein aggregation plays a central role in Parkinson's disease pathology. Direct tr...
alpha-Synuclein has been implicated in the pathogenesis of Parkinson's disease based on mutations in...
International audienceThe pathophysiology of Parkinson's disease, dementia with Lewy bodies, multipl...
ALpha-synuclein (alpha-syn) has been known to be a key player of the pathogenesis of Parkinson's dis...
Abstract Alpha-synuclein (aSyn) plays a crucial role in Parkinson’s disease (PD) and other synuclein...
Cytoplasmic alpha-synuclein (α-syn) aggregates, including Lewy bodies (LBs), are pathological hallma...
Accumulation of pathological alpha-synuclein aggregates plays a major role in Parkinson's diseas...
This concept article aims to show the rationale of targeting extracellular α-Synuclein (α-Syn) from ...